Christopher Hirst, head of RPH Pharmaceuticals at Recipharm, Dr. Damon Smith, CEO at Altus Formulation and Dr. Richard Dart, Executive Director, RADARS System discuss the methods in place to limit abuse of prescription drugs, and the challenges these methods pose to the manufacturer in On Drug Delivery.
The opioid addiction crisis in the US is a pressing problem in healthcare; one many believe may also affect Europe in years to come. The US Centre for Disease Control and Prevention estimates that, from 1999 to 2016, over 200,000 deaths have occurred due to prescription opioid abuse in America.
Abuse deterrent formulations, while not eliminating overdose risk, make it harder for overdose to occur.